The Journal of Clinical Psychiatry

Page 68

More JCP Articles

Commentary

Omega-3 For Perinatal Depression

September 1, 2020

Read a commentary discussing the use of omega-3 fatty acids in the treatment of perinatal depression.

Jerome Sarris , Marlene P. Freeman

Brief Report

Trends in Psychiatric ED Visits Due to Suicidal Ideation and Suicide Attempts During the COVID-19 Pandemic

September 1, 2020

Read a study from Spain comparing the trends in suicide ideation and attempts after the arrival of COVID-19.

Daniel Hernández-Calle , Roberto Mediavilla , Pablo Aguirre , et al

Commentary

Dementia in Older Antidepressant-Treated Adults

August 25, 2020

In this commentary, the authors discuss the article by Bartels and colleagues on the relationship between antidepressant use and risk of incident dementia in older adults.

Eric E. Brown , Tarek K. Rajji , Benoit H. Mulsant

Original Research

Escitalopram in Adolescents With GAD

August 25, 2020

This study evaluated the efficacy and tolerability of escitalopram in adolescents with generalized anxiety disorder as well as the impact of variants in genes and CYP2C19 phenotypes on response…

Jeffrey A. Mills , Heidi Schroeder , Sarah A. Mossman , et al

Original Research

Long-Term Antidepressant Treatment and Risk of Dementia

August 25, 2020

The effects of antidepressants and treatment duration on the progression to dementia are currently unclear. This case-control study analyzed the effects of several antidepressants with different treatment durations on…

Claudia Bartels , Michael Belz , Jonathan Vogelgsang , et al

Original Research

Lithium and Renal Function in Older Adults

August 18, 2020

Lithium is an important mood disorder treatment, but the renal risks in older adults are unclear. This population-based cohort study looked at risk of renal decline with lithium vs…

Soham Rej , Andrea Gruneir , Eric McArthur , et al

Original Research

Long-Term Safety of Aripiprazole Lauroxil

August 18, 2020

Long-acting injectable (LAI) antipsychotics improve adherence, reduce treatment gaps, and improve clinical outcomes. This report describes the long-term safety, tolerability, and symptom trajectory with the LAI antipsychotic aripiprazole lauroxil.

Amy Claxton , Yangchun Du , John Lauriello , et al

Original Research

Switching Antidepressants Following SSRI Failure

August 11, 2020

An antidepressant medication switch often follows a failed initial trial with SSRIs. This study sought to determine the probability and timing of both response and remission and the optimal…

Charles South , Shailesh Bobby Jain , A. John Rush , et al

Letter to the Editor

Clinical Trials With Suicidal Individuals Can Be Conducted Safely

August 4, 2020

This letter, which comments on a recent article by Iltis et al, discusses exclusion of suicidal patients from clinical trials for depression.

Elizabeth D. Ballard , Lawrence T. Park , Maryland Pao

Commentary

HCWs: COVID-19, Mental Health, Suicide Risk

August 4, 2020

Read commentary on mental health needs of health care workers (HCWs), including burnout, PTSD, and suicide risk.

Marilyn L. Piccirillo , Jennifer M. Buchman-Schmitt , Mark A. Reger

Clinical and Practical Psychopharmacology

Using Baclofen for Alcohol Use Disorder

August 4, 2020

Read a review on the use of baclofen for Alcohol use Disorders (AUD) and the risks/benefits of high-dose baclofen.

Chittaranjan Andrade

Review Article

Central and Peripheral Pharmacokinetics of Antipsychotics

July 28, 2020

Pharmacokinetics of antipsychotics are generally slower centrally than peripherally. This review examined the possible dissociation between central D2 receptor occupancy with antipsychotics and their peripheral blood concentrations.

Masaru Mimura , Shin Kurose , Yu Mimura , et al

« 1 … 66 67 68 69 70 … 759 »